We (5) have been concerned with the effect of actinomycin D on bacteriophage T4 infection in cells of Escherichia coli that had been made sensitive to this antibiotic by brief treatment with dilute solutions of ethylenediaminetetraacetate (EDTA) (7). To extend these investigations to a X phage system, we chose to study the effect of actinomycin D on Xvir infection of EDTA-treated cells of E. coli K-12(X). This paper demonstrates that EDTA-treated bacterial cells are unable to adsorb the temperate phages Xvir or 434. In contrast, the adsorption of T-even phages and T5 to these cells is unimpaired.
We (5) have been concerned with the effect of actinomycin D on bacteriophage T4 infection in cells of Escherichia coli that had been made sensitive to this antibiotic by brief treatment with dilute solutions of ethylenediaminetetraacetate (EDTA) (7) . To extend these investigations to a X phage system, we chose to study the effect of actinomycin D on Xvir infection of EDTA-treated cells of E. coli K-12(X). This paper demonstrates that EDTA-treated bacterial cells are unable to adsorb the temperate phages Xvir or 434. In contrast, the adsorption of T-even phages and T5 to these cells is unimpaired.
MATERIALS AND METHODS
Bacterial and phage strains. E. coli K-12(X)thy- (6) and CR 34 (5) have been previously described. E. coli K-12/X and phage Xvir, the virulent multiple mutant of phage X, were originally obtained from A. D. Kaiser. Phage 434 was prepared by induction of the lysogen C600 (434), obtained from M. B. Yarmolinsky. Phage T4d8thy-, a thymine-requiring mutant of T4D, was given to us by I. Tessman (10) .
Phages T2 and T5 were gifts of H. Tabor.
Media. Medium A contained (per liter): glycerol, 5 g; Casamino Acids, 3 g; MgCl2-6H20, 812 mg; CaCl2-2H20, 294 mg; 5OX Vogel-Bonner medium (12) , 10 ml; 1 ml of a solution of trace elements (2), and 13 mg of thymine. Medium B contained VogelBonner medium, MgCl2, and CaCl2 in the same concentrations as in medium A. Medium C consisted of Tryptone broth (3) supplemented with CaCI2 and MgCl2, each at 10-3 M.
Chemicals. Uracil-2-C"4, specific activity 31.3 mc/ mmole, was purchased from New England Nuclear Corp., Boston, Mass. Actinomycin D was a gift from Merck Sharp and Dohme Research Laboratories.
Methods. General bacteriophage techniques were as described by Adams (1) . Infection and adsorption experiments were done at 37 C with vigorous aeration. Experiments with phages T4, Xvir, and 434 were carried out with E. coli K-12(X)thy-as host in medium A, supplemented in T4 studies with 50 ug/ml of tryptophan. Because of difficulties encountered in carrying out satisfactory infection of this bacterial strain with the strains of T2 and T5 available to us, studies with these phages were performed in medium A (T2) or medium C (T5) with E. coli B as host.
The procedure for following the incorporation of uracil-2-C'4 into acid-insoluble material has been previously described (5) .
The method of EDTA treatment of bacterial cells was a modification of that described by Leive (7 dilution fluid lacking Ca++ (6). Cells were removed by low-speed centrifugation, and the supernatant fluids were assayed for free phage. Adsorbed phage was expressed as the difference between free phage present at zero minutes of incubation and free phage present at the time of sampling.
RESULTS
When EDTA-treated cells of E. coli K-12(X)thy-were infected with Xvir, there was a delay of about 40 min in the appearance of intracellular phage ( Fig. 1 ) and in the time at which lysis of the culture began compared with the untreated, infected control. To determine whether this gross delay was due to an inhibition of intracellular processes required for phage development or to impairment of phage adsorption, cells were first infected with Xvir in adsorption medium (medium B) for 5 min, harvested, treated with EDTA, and resuspended in medium A. Under these conditions, the rate of intracellular phage development was similar to the control ( Fig. 1) , lysis began at the expected time, and there was a normal phage burst. These data indicated that the treatment of the cells with EDTA did not in- hibit intracellular functions necessary for phage development.
We next studied the effect of EDTA treatment on the process of phage adsorption. As shown in Fig. 2 (left) , the adsorption of Xvir to EDTAtreated cells of K-12(X)thy-was strikingly impaired. The adsorption of phage 434 to EDTAtreated K-12(X) and of Xvir to EDTA-treated E. coli CR 34 was similarly retarded.
Our previous work (5) had indicated that EDTA treatment of E. coli did not impair phage T4 adsorption, and this fact is directly demonstrated in Fig. 2 To determine whether the effect of EDTA treatment might be to release a component from the cell wall that would specifically and irreversibly interact with X phage to prevent its subsequent adsorption [analogous to the release of the T5 adsorption organ from cell walls of E. coli B by treatment with dilute alkali (13)], the following experiment was performed. Washed cells of K-12(X)thy-were treated with EDTA in the usual manner. The cells were removed by low-speed centrifugation, and the supernatant fluid was diluted 10-fold into fresh medium A. As a control, a solution of 0.05 M Tris-chloride buffer (pH 8.0) containing 2 X 10-4 M EDTA, which had not been in contact with bacterial cells, was similarly diluted into fresh medium A. To each of these tubes, Xvir was added at a concentration of about 4 x 107 per milliliter. The solutions were then aerated at 37 C for 90 min, and samples were removed periodically for assay of phage titer. No phage-inhibiting activity was demonstrable under these conditions. Finally, we investigated the effect of EDTA treatment of a strain of K-12/X to determine whether the treatment might alter the property of resistance to phage X exhibited by these cells. EDTA-treated cells of K-12/X were mixed with Xvir in medium A and incubated at 37 C for 2 hr. During this time, adsorption of Xvir could not be detected, indicating that the cells remained resistant to X after EDTA treatment.
It is apparent in Fig. 2 (left) Uracil-2-C"4, but no actinomycin, was added to one culture at time-zero and isotope incorporation was followed at specified times for the duration ofthe experiment. Uptake in this culture was linear during the experiment and defined the control rate. To parallel cultures, actinomycin (10 ,pg/ml) was added at the times shown by the solid points, uracil-2-C"4 was added I min thereafter, and isotope incorporation was followed in culture samples removed every 2 min over the succeeding 10-min time interval. These points described a rate of uracil incorporation that is expressed in the figure as a percentage of the control rate measured over the same interval. The remainder of the treated cells were suspended at 2 X 108 to 3 X 108 per milliliter in medium B, as was a sample ofcells that had received no EDTA treatment. To the latter cells, which served as control, Xvir was added at 0 min at an input multiplicity of 1:3, and a control rate of phage adsorption was determined. To the EDTA-treated cells, in parallel cultures, )Xvir was added at the same multiplicity at the times shown in the figure by the open circles, and adsorption was measured over the succeeding 8 min. Adsorption rates are expressed in the figure (0) as a percentage ofthe control rate. In each instance, adsorption rate refers to the decrease in free phage that occurred during an 8-min period, a time sufficient to allow maximal phage adsorption to untreated cells (see Fig. 2 , left).
of mitomycin C, that is, under conditions of lysogenic induction.
To test the hypothesis of cell recovery, we com-pared the rate at which EDTA-treated cells regained their normal resistance to actinomycin D, measured by their ability to incorporate uracil into ribonucleic acid in the presence of the antibiotic, with the rate at which Xvir adsorption to these cells returned to control. The results of these experiments (Fig. 3) indicated that cell recovery, as gauged by either of the above parameters, occurred at a similar, although not identical, rate during the 30-min period after completion of EDTA treatment. Thus, the kinetics of adsorption of Xvir to the EDTA-treated cells probably reflect the kinetics of recovery of the cells from the lesion(s) produced by EDTA treatment.
DISCUSSION
Gentle treatment of cells of E. coli with dilute EDTA renders the cells susceptible to actinomycin D (7) , and, in fact, appears to produce a general alteration in cell permeability (8) . It is reasonable to hypothesize that the EDTA treatment is in some way affecting cell-wall structure, but the specific effect of the chelating agent under these conditions remains unknown.
As we have demonstrated in this paper, another consequence of mild EDTA treatment of cells of E. coli is to impair their ability to adsorb phages of the temperate class as exemplified by Xvir and 434. In contrast, the adsorption of phages T2, T4, T6, and T5 to these cells appears to proceed normally. Weissbach and Jacob (14) described a somewhat similar phenomenon, whereby glucosegrown cells of E. coli K-12 also show marked impairment of their ability to adsorb X. It is likely that growth of cells in glucose and treatment of cells with EDTA produce their comparable effect on X adsorption by different mechanisms.
The interpretation of our observations is made difficult by the fact that so very little is known about the normal sequence of events in temperate coliphage adsorption. In contrast to the T-even phages (4), X possesses a long flexible tail that lacks such elements as a contractile sheath, multiple tail spikes and fibers, a cell-wall digesting enzyme, and an energy-generating system. In spite of these striking morphological differences in the two classes of phage, however, the adsorption of either to a bacterial host shares certain common features (see 1, 11) . Thus, adsorption requires the presence of bacterial cell wall and does not occur with spheroplasts. For both types of phage, an essential step in adsorption appears to involve an interaction, in the presence of specific cations, between structural elements presumably on the phage tail, controlled by host-range loci in the phage genome, and specific cell receptors, probably situated in the outer lipoprotein and lipopolysaccharide layers of the cell wall, which are controlled by markers on the bacterial chromosome.
The data we have presented indicate that EDTA impairs temperate phage adsorption as a consequence of an interaction with bacterial cell wall rather than by affecting the phage itself or by altering the cation composition of the adsorption medium. The nature of this interaction is unknown, but two reasonable hypotheses are either that some labile wall component required specifically for temperate phage adsorption is removed, or that EDTA specifically alters the configuration of temperate phage binding sites in such a way that irreversible adsorption cannot occur. The fact that the adsorption defect appears specific for the temperate coliphages and does not affect T phages suggests that there may be fundamental structural differences between the receptor sites employed by these two morphologically dissimilar classes of bacteriophage.
